EasyEquities Blog

Why this JSE Giant Still Trades at a Discount

Written by EasyAssetManagement | Aug 5, 2025 6:00:00 AM

Despite a cleaner portfolio and upcoming liquidity, Reinet trades at a 30%+ discount, what’s keeping sentiment subdued? More from EasyAssetManagement.

Summary

  • Reinet owns valuable investments but its share price is much lower than what those investments are worth. The value of its assets is about €38.54 per share, but the stock trades at around €25.40. That’s a big discount of over 30%.

  • Reinet is selling one of its biggest investments, a company called PICG, for around £2.82 billion. 

  • Even with more transparency and lower management fees (about 0.9% per year), the stock still trades at a big discount which might mean an opportunity for investors if the market starts to see its true value.

Reinet is undergoing a dramatic transformation on the JSE. Once synonymous with tobacco holdings and pension insurance, the group is now on the verge of becoming a cash-heavy vehicle simplified, liquid, and potentially mispriced.

At the heart of this transformation is the pending sale of its crown jewel, Pension Insurance Corporation Group (PICG), and the completed exit from British American Tobacco. The result? A company where vast majority of the NAV could soon be composed of cash or liquid instruments, and where the shares still trade at a significant discount to NAV.

What is Reinet?

Reinet is a Luxembourg-based investment holding company listed on the JSE and the Luxembourg Stock Exchange. Historically, it’s been anchored by legacy positions in:

  • British American Tobacco (now fully exited)

  • Pension Insurance Corporation Group (PICG), which it is in the process of selling.

  • Other Listed and unlisted investments

The company has gradually diversified into a wide array of private equity, listed companies, and Asian investment funds.

 Net Asset Value vs Market Price

As of latest SENS announcement, Reinet reported a NAV of €38.54 per share (as of 30 June), while the stock trades at ~€25.40, indicating a discount of over 30%.

While the sale of PICG is still pending regulatory approval, it already brings one major benefit: a clear, market-anchored valuation for what was Reinet’s largest and most complex unlisted asset. If the deal is concluded, Reinet’s portfolio will be dominated by cash and liquid instruments yet the share continues to trade at a discount to NAV, even though that NAV will potentially soon be made up almost entirely of transparent, verifiable assets.

The Big Deal: PICG Sale

The biggest move this year? Reinet’s planned sale of its 49.5% stake in PICG to Athora Holdings, backed by Apollo Global. The value of the deal implies a ~£2.82B price tag for Reinet’s stake. While the deal implies a haircut to Reinet’s previous internal valuation of PICG, it achieves a clean exit and unlocks liquidity.

Notably, Reinet originally invested ~£1.1B into PICG and has already received £426M in dividends, overall, a positive return on investment

 Portfolio Breakdown


Here’s how Reinet’s portfolio looks going forward:

📈 Listed Investments (€125M)

  • Grab Holdings, Twist Bioscience, SPDR Gold ETF, Soho China, Cartesian Therapeutics: Small, diversified positions with some growth optionality.

Unlisted:


PICG (Pension Insurance Corporation Group): Pending regulatory approval for sale to Athora. As of 31 March 2025, Reinet valued its 49.5% stake in PICG at ~€3.72B.

🔒 Private Equity & Partnerships (~€1.2B)

  • Trilantic & TruArc (North American & European PE funds): €424M and €198M, respectively

  • NanoDimension, Asia Partners, Prescient China, and others: targeting biotech, Asia tech, and quant equity strategies.

Other

  • US land development and mortgages: €30M

  • Other investments: €55M

 Discount: Still Too Wide?

Holding companies often trade at a NAV discount. But in Reinet’s case, the usual justifications, opaque unlisted assets and fee drag are starting to fade.

  • Fees: Management and performance fees totalled €59 for the year equating to roughly ~0.9% of average NAV definitely not egregious.

  • Transparency: The portfolio is becoming cleaner, with much more liquid assets as a result if the BAT exit as well as the pending sale of the PICG     

As a result of these factors, it’s becoming increasingly harder explain the companies large discount to NAV, unless the market believes capital redeployment will be lacklustre or will destroy value. Additionally, perhaps the share class structure that allows management to retain tight control barring shareholder activism has investors worried.

What Happens Next?

The real question is: what will Reinet do with the cash?

There are no plans for special dividends or share buybacks. Instead, management has made it clear, most recently via SENS, that “Reinet Fund S.C.A., F.I.S. intends using the proceeds from this transaction for its ongoing investment activity.” This seems to be instep Johann Rupert’s observed investment approach: prioritising patient capital and long-term compounding. But it may frustrate investors hoping for a capital return, especially given the scale of the cash inflow.

Nevertheless, execution risk looms, can they find deals as accretive as PICG?

The Setup

Reinet is on the cusp of becoming a leaner, cash-rich, and far more liquid investment vehicle. With the BAT exit complete and the PICG sale pending, the company is shifting away from complex legacy holdings toward a simplified, transparent balance sheet, one that could be made up mostly of cash and liquid instruments.

Yet, despite this transformation, the share still trades at a material discount to NAV and even, potentially, to its expected cash and liquid assets position should the PICG close. That creates an asymmetric setup: limited downside (thanks to a cash-backed NAV and clearer asset valuation) with significant upside if the discount narrows and investor confidence improves.

A re-rating may be warranted but it may hinge on what Reinet does next.

EasyAssetMangement continues to monitor Reinet in line with our EasyETFs Balanced Actively Managed ETF  strategy. If you are looking for exposure to global or AI themed equities check out our EasyETFs Global Equity Actively Managed ETF and our EasyETFs AI World Actively Managed ETF.

Discover more insights in our blogs



Any opinions, news, research, reports, analyses, prices, or other information contained within this research is provided by an employee of EasyEquities an authorised FSP (FSP no 22588) as general market commentary and does not constitute investment advice for the purposes of the Financial Advisory and Intermediary Services Act, 2002. First World Trader (Pty) Ltd t/a EasyEquities (“EasyEquities”) does not warrant the correctness, accuracy, timeliness, reliability or completeness of any information (i) contained within this research and (ii) received from third party data providers. You must rely solely upon your own judgment in all aspects of your investment and/or trading decisions and all investments and/or trades are made at your own risk. EasyEquities (including any of their employees) will not accept any liability for any direct or indirect loss or damage, including without limitation, any loss of profit, which may arise directly or indirectly from use of or reliance on the market commentary. The content contained within is subject to change at any time without notice.